Changes in anticoagulant and antiplatelet drug supply at US hospitals before and during the COVID-19 pandemic (2018-2021)
CONCLUSION: Rapid changes in anticoagulant and antiplatelet volume at US hospitals during the COVID-19 pandemic highlight the need for institutional protocols to manage fluctuating medication volume demands.PMID:36571281 | DOI:10.1093/ajhp/zxac381
Source: American Journal of Health-System Pharmacy : AJHP - Category: Drugs & Pharmacology Authors: Paul J Wong Scott A Mosley Tien M H Ng Andrew Shooshtari G Caleb Alexander Dima M Qato Source Type: research
More News: Coronavirus | COVID-19 | Drugs & Pharmacology | Eptifibatide | Integrilin | Lovenox | Pandemics | Study